journal articleLitStream CollectionLetter urges UK Govt to review human-biology-based tests2013 Reactions Weeklydoi: 10.2165/00128415-201113560-00001pmid: N/A
journal articleLitStream CollectionFrance, Germany suspend pioglitazone2013 Reactions Weeklydoi: 10.2165/00128415-201113560-00003pmid: N/A
journal articleLitStream CollectionUS FDA streamlines safety reporting in clinical trials2013 Reactions Weeklydoi: 10.2165/00128415-201113560-00004pmid: N/A
journal articleLitStream CollectionRituximab linked to fatal infusion-related reactions2013 Reactions Weeklydoi: 10.2165/00128415-201113560-00002pmid: N/A
journal articleLitStream CollectionThe EMA's CHMP has finalised its review of the use of the COX-2 inhibitor celecoxib2013 Reactions Weeklydoi: 10.2165/00128415-201113560-00008pmid: N/A
journal articleLitStream CollectionFDA warns of serious prostate cancer with 5-αRIs2013 Reactions Weeklydoi: 10.2165/00128415-201113560-00007pmid: N/A
journal articleLitStream CollectionWinthrop Pharmaceuticals UK Ltd (trading as Zentiva) has issued a “Dear Healthcare Provider” letter2013 Reactions Weeklydoi: 10.2165/00128415-201113560-00005pmid: N/A
journal articleLitStream CollectionNew restrictions on use of high-dose simvastatin2013 Reactions Weeklydoi: 10.2165/00128415-201113560-00006pmid: N/A
journal articleLitStream CollectionPotential link between liraglutide use and thyroid cancer2013 Reactions Weeklydoi: 10.2165/00128415-201113560-00011pmid: N/A
journal articleLitStream CollectionLink between 5-αRIs and high-grade prostate cancer2013 Reactions Weeklydoi: 10.2165/00128415-201113560-00009pmid: N/A